منابع مشابه
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
BACKGROUND Ferric carboxymaltose (FCM) and iron isomaltoside 1000 (IIM) are increasingly used because they allow correction of severe iron deficiency in a single infusion. A transient decrease in serum phosphate concentrations is a frequent side effect of FCM. AIM To characterize this adverse event and search for its predictors in a gastroenterology clinic patient cohort. METHODS Electronic...
متن کاملRespiratory illness and hypophosphatemia.
We retrospectively reviewed the charts of 308 admissions to a pulmonary disease ward and 100 admissions to the general medical service over one year to find the prevalence, sequelae, and etiology of hypophosphatemia. The overall prevalence of low serum phosphate levels (less than 2.4 mg/dl) occurring at least once during hospitalization in chest patients was 17 percent, but was higher in patien...
متن کاملHypophosphatemia in hospitalized patients.
Hypophosphatemia is common in hospitalized patients and occurs under a variety of circumstances other than parathyroid hormone excess. Charts of 100 inpatients with hypophosphatemia were reviewed and the patients divided into five groups on the basis of serum phosphate level: 18, 2.1 to 2.4 mg/dL; 49, 1.6 to 2.0 mg/dL; 20, 1.1 to 1.5 mg/dL; 12, 0.6 to 1.0 mg/dL; 1, 0.1 to 0.5 mg/dL. The effect ...
متن کاملCoastal vegetation invasion increases greenhouse gas emission from wetland soils but also increases soil carbon accumulation.
Soil properties and soil-atmosphere fluxes of CO2, CH4 and N2O from four coastal wetlands were studied throughout the year, namely, native Kandelia obovata mangrove forest vs. exotic Sonneratia apetala mangrove forest, and native Cyperus malaccensis salt marsh vs. exotic Spartina alterniflora salt marsh. Soils of the four wetlands were all net sources of greenhouse gases while Sonneratia forest...
متن کاملFibroblast Growth Factor 23 and Hypophosphatemia: A Case of Hypophosphatemia along the Rickets-Osteomalacia Spectrum.
Phosphorus is a key component of bone, and a deficiency results in poor mineralization along with other systemic symptoms of hypophosphatemia. Various causes of hypophosphatemia with renal wasting of phosphorus have been identified. These include the Fanconi syndrome, various genetic mutations of fibroblast growth factor 23 (FGF23) handling and the sodium/phosphate cotransporter, and those due ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Deutsches Aerzteblatt Online
سال: 2012
ISSN: 1866-0452
DOI: 10.3238/arztebl.2012.0492b